Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Whitehawk Therapeutics, Inc.
| Metric | Whitehawk Therapeutics, Inc. WHWKHealthcare |
|---|---|
| Quality Score | 33 / 100 |
| Revenue (latest) | $7M |
| Net income (latest) | −$21M |
| Operating margin | −1601.1% |
| Net margin | −288.3% |
| Return on equity | −15.1% |
| Return on assets | −13.7% |
| Return on capital (ROCE) | −83.9% |
| Debt / equity | 0.11× |
| Revenue growth (YoY) | −72.5% |
| Altman Z″ (distress) | 2.98 |
| Accruals / assets | 50.9% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.